Thomas D. Carey bought $47K of LAB stock

Thomas D. Carey, Dir of Standard Biotools Inc. (LAB), bought 75,000 shares of LAB stock worth $47K, per an SEC Form 4 filed Nov 5, 2026.

It was an open-market purchase.

The trade was reported on Nov 5, 2026.

LAB has moved +2.2% since the trade date, from $0.62 to $0.64 (Nov 6, 2026 close).